Large scale functional genomics strategies for enabling cancer precision medicine by identification of new drug targets and risk alleles
Associate Professor Joseph (Sefi) Rosenbluh
Monash Biomedicine Discovery Institute
A/Prof Rosenbluh will discuss how revolutionary CRISPR technologies such as base editors and RNA-Seq (CROPSeq) are identifying new drug targets for known oncogenes and new types of gene dependencies in colon, gastric and breast cancers.
Event Details
This event will be held online via Zoom. Zoom joining details will be circulated one hour prior to the commencement of the event.
To join this event visit:
https://monash.zoom.us/j/88949702777?pwd=eHNLVWpMcklnU1R4R2dXbm9MbnUvZz09
